Passionflower in the treatment of generalized anxiety: a pilot double‐blind randomized controlled trial with oxazepam

@article{Akhondzadeh2001PassionflowerIT,
  title={Passionflower in the treatment of generalized anxiety: a pilot double‐blind randomized controlled trial with oxazepam},
  author={Shahin Akhondzadeh and H Naghavi and M Vazirian and Anooshirvan Shayeganpour and H Rashidi and Mousa Khani},
  journal={Journal of Clinical Pharmacy and Therapeutics},
  year={2001},
  volume={26}
}
Objective: Passionflower (Passiflora incarnata) is a folk remedy for anxiety. A double‐blind randomized trial compared the efficacy of Passiflora incarnata extract with oxazepam in the treatment of generalized anxiety disorder. 
Passionflower Extract Improves Diurnal Quality of Life in Japanese Subjects with Anxiety: A Randomized, Placebo-controlled, Double-blind Trial
TLDR
In intake of PFE (200 mg/day for 12 weeks) improved several emotional parameters related to daytime social and mental activities and none of the OSA sleep score parameters were significantly improved by PFE compared with placebo.
A Double‐blind, Placebo‐controlled Investigation of the Effects of Passiflora incarnata (Passionflower) Herbal Tea on Subjective Sleep Quality
TLDR
The initial findings suggest that the consumption of a low dose of Passiflora incarnata, in the form of tea, yields short‐term subjective sleep benefits for healthy adults with mild fluctuations in sleep quality.
Herbal Anxiolytics with Sedative Actions
TLDR
This chapter will present evidence from human clinical trials regarding the efficacy of herbal treatments with a primarily sedative mode of action for chronic (everyday) supplementation to address anxiety symptoms.
Effects of Passion Flower Extract, as an Add-On Treatment to Sertraline, on Reaction Time in Patients ‎with Generalized Anxiety Disorder: A Double-Blind Placebo-Controlled Study
TLDR
It is noted that passion flower might be suitable as an add-on in the treatment of generalized ‎anxiety disorder with low side effects.
Fixed herbal drug combination with and without butterbur (Ze 185) for the treatment of patients with somatoform disorders: randomized, placebo‐controlled pharmaco‐clinical trial
TLDR
The aim of the present short‐term study was to evaluate in a pharmaco‐clinical trial the additional benefit of butterbur in a fixed herbal drug combination in patients with somatoform disorders.
Antianxiety Activities Associated with Herbal Drugs: A Review
TLDR
Objective of this review examines herbs commonly used for generalized anxiety and some other psychiatric symptoms and advantages associated with their use.
Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: A randomized controlled trial
TLDR
NSF-3 is a safe and effective short-term alternative to zolpidem for primary insomnia and it remains to be explored whether the benefits are sustained and whether there is dependence liability with this formulation upon long term use.
Saffron, passionflower, valerian and sage for mental health.
TLDR
Clinical relevant scientific information on medicinal extracts of 4 herbs: saffron, passionflower, valerian, and sage is discussed.
Herbal remedies for depression and anxiety
TLDR
Only two of these herbal remedies are supported by sound evidence: Hypericum perforatum (St John’s wort) for mild to moderate depression and Piper methysticum (kava) for anxiety.
Herbal remedies for anxiety - a systematic review of controlled clinical trials.
  • E. Ernst
  • Medicine
    Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 2006
TLDR
It was concluded that there is a lack of rigorous studies in this area and that only kava has been shown beyond reasonable doubt to have anxiolytic effects in humans.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 37 REFERENCES
Double-blind comparison of buspirone and clorazepate in anxious outpatients.
TLDR
In this study, buspirone was shown to be an effective antianxiety agent, causing significantly less sedation than clorazepate, and the profile of side effects was dissimilar.
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
TLDR
There was a significant increase in symptom severity consistent with a withdrawal reaction for the clorazepate group but not the buspirone group, and there was a suggestion that previous discontinuous exposure to benzodiazepines might sensitize patients to subsequent withdrawal effects.
Long-term diazepam therapy and clinical outcome.
TLDR
It is indicated that a significant number of patients benefit from prolonged diazepam treatment and that tolerance to the anxiolytic effect of diazepAM does not develop during a 22-week study period.
Current Status of Benzodiazepines
TLDR
When the pharmacologic and clinical properties of the benzodiazepine sedative–anxioly tics were last reviewed comprehensively in 1973 and 1974, concern emerged among both prescribers and users of these medications about this continuously increasing use.
Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers
TLDR
The psychomotor/cognitive performance, subject-rated, and observer-rated effects of single oral doses of the benzodiazepine hypnotic triazolam and the imidazopyridine hypnotic zolpidem were compared in 11 volunteers, in a double-blind, placebo-controlled, crossover design.
Generalized anxiety disorder: Some biochemical aspects
TLDR
This group was compared to 15 normal controls who also had their blood drawn after a 20-min rest period, and the two groups were initially found to have significantly different levels of plasma free MHPG through the use of t tests.
Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment
Peripheral‐type benzodiazepine receptors were measured in human circulating lymphocytes using 3H‐PK 11195 as specific ligand. In a group of outpatients with anxiety disorders a significant decrease
Benzodiazepines, amnesia and sedation: Theoretical and clinical issues and controversies
The amnestic effect of benzodiazepines, first described in 1965, and the subsequent attempts to identify the precise nature of this effect, are reviewed. The difficulty in deciding to what extent
GABA(A)-receptor subtypes: a new pharmacology.
TLDR
The GABA(A) receptor is a pluripotent drug target mediating anxiolytic, sedative, anticonvulsant, muscle relaxant and amnesic activity and precise guidelines for the development of novel drugs with more selective action and less side effects are available.
Behavioral Pharmacology of Zolpidem Relative to Benzodiazepines A Review
  • C. R. Rush
  • Medicine, Psychology
    Pharmacology Biochemistry and Behavior
  • 1998
TLDR
The most parsimonious conclusion is that despite its unique neuropharmacological profile, the behavioral effects of zolpidem are generally similar to those of benzodiazepines.
...
1
2
3
4
...